Lena Blümel

Tacedinaline (CI-994), a class I HDAC inhibitor, targets intrinsic tumor growth and leptomeningeal dissemination in MYC-driven medulloblastoma while making them susceptible to anti-CD47-induced macrophage phagocytosis via NF-kB-TGM2 driven tumor inflammation

Viktoria Marquardt, Johanna Theruvath, David Pauck et al. · Journal for ImmunoTherapy of Cancer · 2023 · 60 citations · Full text

Medicine, Oncology, Pharmacology +17

Influence of secreted frizzled receptor protein 1 (SFRP1) on neoadjuvant chemotherapy in triple negative breast cancer does not rely on WNT signaling

Christof Bernemann, Carolin Hülsewig, Christian Rückert et al. · Molecular Cancer · 2014 · 59 citations · Full text

Medicine, Cancer Biology, Oncology +13

The long non-coding RNA HOTAIRM1 promotes tumor aggressiveness and radiotherapy resistance in glioblastoma

Ulvi Ahmadov, Daniel Picard, Jasmin Bartl et al. · Cell Death and Disease · 2021 · 54 citations · Full text

Life Sciences, Genetics, Oncology +17

Intratumoral heterogeneity of MYC drives medulloblastoma metastasis and angiogenesis

Nan Qin, Eunice Paisana, Maike Langini et al. · Neuro-Oncology · 2022 · 38 citations

Medicine, Cancer Biology, Oncology +17

The HHIP-AS1 lncRNA promotes tumorigenicity through stabilization of dynein complex 1 in human SHH-driven tumors

Jasmin Bartl, Marco Antônio Zanini, Flavia Bernardi et al. · Nature Communications · 2022 · 33 citations · Full text

Medicine, Molecular Biology, Oncology +13